Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on: February 18,2024

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on:February 18,2024

Researchers discover new pathways to activate dendritic cells, produce strong anti-tumor immunity

by H. Lee Moffitt Cancer Center & Research InstituteArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Cre

Updated on: January 30,2024

Researchers discover new pathways to activate dendritic cells, produce strong anti-tumor immunity

by H. Lee Moffitt Cancer Center & Research InstituteArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Cre

Updated on:January 30,2024

Researchers identify neurotransmitter that helps cancers progress

by Johns Hopkins University School of MedicineUsing human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotrans

Updated on: June 15,2024

Researchers identify neurotransmitter that helps cancers progress

by Johns Hopkins University School of MedicineUsing human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotrans

Updated on:June 15,2024

Study reveals factors that influence participation in bowel cancer screening

by Isabelle Dubach,University of New South WalesCredit: Unsplash/CC0 Public DomainA new, Australian-first study by Cancer Council NSW has shed light on the factors that influence whether or not

Updated on: July 02,2024

Study reveals factors that influence participation in bowel cancer screening

by Isabelle Dubach,University of New South WalesCredit: Unsplash/CC0 Public DomainA new, Australian-first study by Cancer Council NSW has shed light on the factors that influence whether or not

Updated on:July 02,2024

Researchers use AI to understand lung cancer cell vulnerabilities

by University of MontanaMark Grimes, a researcher and University of Montana biology professor, uses AI to learn more about lung cancer vulnerabilities. Credit: University of Montana photo by Tomm

Updated on: February 18,2024

Researchers use AI to understand lung cancer cell vulnerabilities

by University of MontanaMark Grimes, a researcher and University of Montana biology professor, uses AI to learn more about lung cancer vulnerabilities. Credit: University of Montana photo by Tomm

Updated on:February 18,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on: March 20,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on:March 20,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on: March 01,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on:March 01,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on: March 06,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on:March 06,2024

Care at high-volume radiation treatment centers tied to higher survival

by Lori SolomonAmong men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug.

Updated on: February 01,2024

Care at high-volume radiation treatment centers tied to higher survival

by Lori SolomonAmong men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug.

Updated on:February 01,2024

Novel bioassay predicts cancer patients' response to immunotherapy

byBen-Gurion University of the NegevIcAR response to fresh and fixed PDXs and generation of an IcAR score.(A) Schematic representation of the IcAR assay protocol. Following flow cytometry determ

Updated on: January 12,2024

Novel bioassay predicts cancer patients' response to immunotherapy

byBen-Gurion University of the NegevIcAR response to fresh and fixed PDXs and generation of an IcAR score.(A) Schematic representation of the IcAR assay protocol. Following flow cytometry determ

Updated on:January 12,2024

Study discovers triple immunotherapy combination as possible treatment for pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on: January 30,2024

Study discovers triple immunotherapy combination as possible treatment for pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on:January 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024